logo
Tariff talks continue, as job losses loom in Switzerland

Tariff talks continue, as job losses loom in Switzerland

RTÉ News​5 days ago
Switzerland is continuing discussions with the United States about reducing tariffs, its government said on Friday, as economists warned some industries would suffer "severe" job losses from the 39% tariff imposed by the US on Swiss imports.
The talks in Washington are being led by Helene Budliger Artieda, head of the State Secretariat for Economic Affairs (SECO), and come after the import levy - among the highest of any applied under President Donald Trump's global trade reset - took effect on Thursday.
A last-ditch effort by a Swiss delegation to Washington, which included President Karin Keller-Sutter, had failed to produce a better deal.
"Discussions with the United States are ongoing," SECO said in a statement to Reuters on Friday. "The discussions have consistently focused on reducing the additional US tariffs."
SECO said it would give no further details on the talks, which could include further concessions Switzerland may offer the US in return for lower tariffs.
Economist Hans Gersbach, from the KOF Economic Institute at ETH, a university in Zurich, estimated that 7,500 to 15,000 jobs could be lost in Switzerland as a result of the US tariffs.
"The effect will be severe in some industries like watches, machinery and precision instruments," Gersbach said.
"If pharma was also targeted, the figure would be higher," he added, although no figure has yet been calculated.
Switzerland's giant pharmaceuticals sector, which includes Roche and Novartis, made up half of Swiss exports to the US last year, and has not been included in the US tariffs.
Business association economie suisse held a seminar earlier this week to help companies navigate the tariff turmoil.
Companies were very concerned, but were focused on trying to find solutions, said economie suisse board member Jan Atteslander.
"We still have difficulties understanding this friendly fire, but we are working on ways to cope with it," Atteslander said.
US importers would increase their prices for Swiss products to deal with the tariff impact, Atteslander said, which could lead to lower sales, while profit margins would also be cut.
Companies were speaking with their US customers as well as examining shifting their production from Switzerland to Europe or Britain, which have lower tariffs on US-bound products.
The crisis is the latest shock to hit Swiss companies, which have long battled an appreciating Swiss franc, which makes its products more expensive abroad, said Atteslander.
"We will cope with it, it's a pressure we are used to," he said. "Our companies are always under heavy pressure, so the only way to survive is to innovate."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Roche Ireland clean up bill for Irish manufacturing site now totals €150.5m
Roche Ireland clean up bill for Irish manufacturing site now totals €150.5m

RTÉ News​

time39 minutes ago

  • RTÉ News​

Roche Ireland clean up bill for Irish manufacturing site now totals €150.5m

The clean-up bill for Swiss pharma giant Roche's former Co Clare manufacturing site now totals €150.5m in what the company describes as "one of the largest remediation projects of its type in Europe". New accounts show that Roche Ireland Ltd recorded losses of €54.9m in 2024 as its decommissioning and remediation spend concerning its decision to exit manufacturing here continued to mount and now totals €150.5m over five years. The €54.9m loss for 2024 includes a combined spend of €48.26m on environmental and demolition costs which is the highest spend on environmental costs across the project that has been ongoing since 2020. The plant was once one of the most prestigious places of employment in the Midwest and the pharma giant announced its decision in 2016 to shut down its Clarecastle plant with the loss of 240 jobs. After the firm failed to secure a buyer for the pharma site, it set about decommissioning the site and demolishing its fine chemical manufacturing plant "to a brown field status" which would be capable of attracting new investment. The €54.96m loss for 2024 followed losses of €42.93m in 2023 and losses of €26.15m in 2022 and the losses chiefly relate to the environmental spend. The new accounts show that the company's "environmental" spend last year totalled €44m which was an increase on the €38.66m spent under that heading in 2023. The company's demolition costs last year totalled €4.5m. A spokeswoman for Roche Ireland said today "five years into the project, the final phase of decommissioning - the remediation of three specified areas on-site, including the removal of a legacy landfill - is now underway and is scheduled to be completed by year-end 2027". The Irish unit during last year received a €55m capital contribution from a connected Roche entity to fund the programme and this followed a capital contribution of €43m in 2023. The Roche Ireland spokeswoman described the remediation scheme as "gold standard, over and above Roche Ireland Limited's statutory environmental obligations in Ireland". "The project is one of the largest remediation projects of its type in Europe, providing employment for, on average, 100 people," she said. "The funding committed to the project by a company exiting manufacturing activities in Ireland is unique," she added. "With decommissioning well advanced, Roche Ireland Limited is now focused on working with key stakeholders to identify new investors for this strategically positioned site in Co. Clare," she stated. She said that when the remediation project is complete, the company will have met its two objectives - delivering a brownfield site with the potential to deliver sustainable jobs under a new investor and leaving a positive legacy for the local community, Clare and Ireland. Excavation at the first area of environmental concern was completed in January 2024, with 17,500 tonnes of contaminated soil transported off-site in 674 sealed containers to a licensed thermal treatment facility in Holland. Groundwater purification of that area is currently underway.

Glanbia outlines financial performance for first half of 2025
Glanbia outlines financial performance for first half of 2025

Agriland

time4 hours ago

  • Agriland

Glanbia outlines financial performance for first half of 2025

Glanbia plc has announced its half-year (HY) financial results for the six-month period ended July 5, 2025. The business said it delivered a "resilient" financial and operating performance in HY 2025. Group revenue was $1.93 billion (HY 2024: $1.82 billion), up 6% on the same period last year. The group EBITDA (earnings before interest, taxes, depreciation, and amortisation) was $241 million (HY 2024: $261 million), down 7.5%. The group pre-exceptional profit after tax was $132 million (HY 2024: $152 million), down 13.3%. Adjusted earnings per share (EPS) was 63.03 (US) cent (HY 2024: 68.2 US cent), down 7.5%. Glanbia's net debt at July 5, 2025 was $650 million (HY 2024: $645 million), which represents an increase of $4.6 million versus the prior year. The ratio of net debt to EBITDA was 1.28 (HY 2024: 1.22). At the end of the HY, the group had committed debt facilities of $1.37 billion (HY 2024: $1.3 billion). Glanbia's total investment in capital expenditure (strategic and maintenance) was $47.7 million in the first half of 2025 (HY 2024: $44.9 million). Strategic investment totalled $34.2 million and included ongoing capacity enhancement, business integrations, and information technology (IT) investments, Glanbia said. Total capital expenditure for the year is expected to be between $80 million and $90 million. The board of Glanbia plc is recommending an interim dividend of 17.2 (euro) cent per share (HY 2024: 15.64 euro cent per share), representing a 10% increase on the prior year interim dividend. Glanbia said its overall dividend policy remains unchanged at a target annual dividend payout ratio of between 25% and 35% of EPS. The interim dividend will be paid on October 3, 2025 to shareholders on the register of members as at August 22, 2025. Irish withholding tax will be deducted at the standard rate where appropriate. Euro remains the group's primary dividend payment currency. On November 6, 2024, the group announced a €50 million share buyback programme which formally commenced on December 16, 2024. This programme was completed on May 30, 2025 and another €50 million share buyback programme launched on June 4, 2025. Year-to-date to July 5, 2025, Glanbia has deployed €62.8 million, repurchasing 5,095,246 ordinary shares on Euronext Dublin at an average price of €12.33. A further €50 million share buyback programme is expected to be concluded prior to year end. The group is revising its guidance for adjusted EPS for 2025 to 130-133 (US) cent (the previous guidance was 124-130 US cent). The updated guidance still represents a decline of between 5% and 7% annually. Glanbia said this revised EPS is expected to be driven by: Performance Nutrition (PN) division 'like-for-like' revenue growth of 2% to 3% (excluding the impact of SlimFast and Body & Fit); PN EBITDA margins in the range of 13% to 14%; Health & Nutrition (H&N) like-for-like revenue growth of "mid-single digit"; H&N EBITDA margin in the range of 18% to 19%; Profit growth across Dairy Nutrition (DN) and the group's US joint venture, combined. Glanbia also expects to deliver an operating cash flow conversion rate of 80%+ in the full year (FY) 2025. Commenting on these results, Glanbia chief executive Hugh McGuire said: "Today's results reflect a first half of significant execution and progress as we generated 6% revenue growth in the period, underpinned by strong growth in H&N and DN and a sequential improvement in PN through the period as the group navigated significant macroeconomic volatility. "First half results were driven by volume growth, earnings and margin progression in H&N and DN, reflecting strong customer demand. This was offset by anticipated reduced performance in PN primarily as a result of elevated whey costs during the period. "In the second quarter, we were pleased to see volume and price growth in our flagship brand, Optimum Nutrition. Within our H&N division, we have today announced the acquisition of Sweetmix, a Brazil-based nutritional premix and ingredients solutions business, facilitating continued growth in the Latin America region," McGuire added. The acquisition of Sweetmix is at an initial consideration of $41 million. Revenue for Sweetmix in 2024 was approximately $17 million.

Israel military says 'approved' plan for new Gaza offensive
Israel military says 'approved' plan for new Gaza offensive

RTÉ News​

time5 hours ago

  • RTÉ News​

Israel military says 'approved' plan for new Gaza offensive

The Israeli military has said chief of staff Eyal Zamir has approved the "framework" for a new offensive in Gaza. Israel has said it will launch a the offensive and seize control of Gaza City, which it captured shortly after the war's outbreak in October 2023 before pulling out. Israeli planes and tanks kept up their bombardment of eastern areas of Gaza City overnight. Meanwhile, Hamas leader Khalil Al-Hayya arrived in Cairo yesterday for talks to revive a US-backed ceasefire plan. The latest round of indirect talks in Qatar ended in deadlock in late July with Israel and Palestinian militant group Hamas trading blame over the lack of progress on a US proposal for a 60-day truce and hostage release deal. Hamas' meetings with Egyptian officials, scheduled to begin today, will focus on ways to stop the war, deliver aid, and "end the suffering of our people in Gaza," Hamas official Taher al-Nono said in a statement. Foreign ministers of 24 countries said yesterday that the humanitarian crisis in Gaza had reached "unimaginable levels" and urged Israel to allow unrestricted aid into the territory. Israel denies responsibility for hunger in Gaza, accusing Hamas of stealing aid. It says it has taken steps to increase deliveries, including pausing fighting for parts of the day in some areas and announcing protected routes for aid convoys. A Palestinian official with knowledge of the mediated ceasefire talks said Hamas was prepared to return to the negotiating table, and the leaders who were visiting Cairo yesterday would reaffirm that stance. Latest Middle East stories "Hamas believes negotiation is the only way to end the war and is open to discuss any ideas that would secure an end to the war," the official, who asked not to be named due to the sensitivity of the matter, said. However, the gaps between the sides appear to remain wide on key issues, including the extent of any Israeli military withdrawal and demands for Hamas to disarm. A Hamas official said the Islamist movement was ready to relinquish Gaza governance on behalf of a non-partisan committee, but it would not relinquish its arms before a Palestinian state is established. Israeli Prime Minister Benjamin Netanyahu, whose far-right ultranationalist coalition allies want an outright Israeli takeover of all of Gaza, has vowed the war will not end until Hamas is eradicated. The war began on 7 October 2023, when Hamas-led militants stormed into southern Israel, killing 1,200 people and taking 251 hostages, according to Israeli figures. Israel's offensive against Hamas in Gaza since then has killed more than 61,000 Palestinians, according to local health officials.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store